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Abstract
Background: Lactic acid, a natural by-product of glycolysis, is produced at excess levels in response to impaired
mitochondrial function, high-energy demand, and low oxygen availability. The enzyme involved in the production of b-
amyloid peptide (Ab) of Alzheimer’s disease, BACE1, functions optimally at lower pH, which led us to investigate a potential
role of lactic acid in the processing of amyloid precursor protein (APP).
Methodology/Principal Findings: Lactic acid increased levels of Ab40 and 42, as measured by ELISA, in culture medium of
human neuroblastoma cells (SH-SY5Y), whereas it decreased APP metabolites, such as sAPPa. In cell lysates, APP levels were
increased and APP was found to interact with ER-chaperones in a perinuclear region, as determined by co-
immunoprecipitation and fluorescence microscopy studies. Lactic acid had only a very modest effect on cellular pH, did
increase the levels of ER chaperones Grp78 and Grp94 and led to APP aggregate formation reminiscent of aggresomes.
Conclusions/Significance: These findings suggest that sustained elevations in lactic acid levels could be a risk factor in
amyloidogenesis related to Alzheimer’s disease through enhanced APP interaction with ER chaperone proteins and aberrant
APP processing leading to increased generation of amyloid peptides and APP aggregates.
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Introduction
Early-onset, autosomal dominant, familial Alzheimer’s disease
(AD) is caused by mutations in proteins that participate in the
genesis of amyloid peptides. Mutations in APP, the progenitor of
Ab peptides, are a documented cause of AD as are mutations in 2
proteins, presenilin 1 and presenilin 2, which are components of a
proteolytic enzymatic complex that is directly involved in the
processing of APP[1]. Multiple studies have established that the
net effect of these mutations is to increase the relative proportion
of Ab42 peptide that is generated by APP processing or to increase
overall Ab42 production [2]. Thus, these familial forms of the
disease establish increased Ab42 production as one mechanism by
which the onset of AD can be hastened. However, few cases of AD
are either early-onset or inherited. For the vast majority of these
cases, the causative factors, other than aging, are less clear.
A common characteristic of many metabolic and vascular
diseases is increased production of lactic acid. High lactate levels
are found in affected tissues of individuals with disease caused by
mitochondrial mutations, leading to mitochondria dysfunction [3].
Stroke and cerebral ischemia are associated with stimulation of
glycolysis due to low availability of oxygen, resulting in increased
levels of lactate in the brain [4]. Relevant to the present study, the
levels of lactate in the cerebrospinal fluid (CSF) of AD patients has
been reported to be elevated [5] and one of the enzymes critical to
the production of Ab peptides, b-amyloid cleaving enzyme
(BACE1), is strongly influenced by pH, with an optimal pH well
below 6.0 [6]. Thus lactic acid has the potential to be a natural
modulator of APP processing and Ab production in the brain.
Endoplasmic reticulum (ER) stress has been shown to be associated
with neurodegenerative disorders including AD [7] and the ER
chaperone protein, glucose-regulated protein 78 (Grp78) was demon-
s t r a t e dt ob i n dA P Pa n dm o d i f yA P Pp r o c e s s i n gin vitro [8,9], and was
f o u n di nac o m p l e xw i t hA P Pin vivo [10]. Since lactic acidosis is one of
the many stressors that elicit an ER stress response, the effect of lactic
acid on APP processing in the context of ER chaperone regulation was
explored. We report here a novel role of lactic acid in activating an ER
chaperone-APP interaction, modifying APP trafficking, increasing Ab
peptide generation and APP aggregate formation.
Results
To study the effects of lactic acid on APP processing, we chose
to use the human neuroblastoma cell line SH-SY5Y. These cells
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e13820are known to express human amyloid precursor proteins and
produce human Ab peptides and have been widely used to study
APP processing [11].
First, the effect of lactic acid on the extra- and intracellular pH
was determined. SH-SY5Y cells were incubated with a pH-
sensitive dye (BCECF, AM) and changes in cell fluorescence upon
exposure to lactic acid were determined using confocal microsco-
py. SH-SY5Y cells were exposed for 6 h to 6 mM and 12 mM
lactic acid, which are concentrations within the physiological
range of lactic acid measured in the blood at rest (,1.5 – 4.5 mM)
and shortly after strenuous exercise (,10 – 14 mM) respectively
[12,13]. In the presence of 6 mM and 12 mM lactic acid, the
cytosolic pH was lowered from pH 7.1 to pH 6.6 and 6.4,
respectively (Fig. 1A), which paralleled a lowering of the pH in the
cell culture medium (pH 7.2 under control conditions, pH 7.0 at
6 mM lactic acid and pH 6.7 at 12 mM lactic acid, respectively)
(Fig. 1B). No substantial effects on cell viability were observed at
these concentrations of lactic acid, although higher concentrations
(up to 30 mM) did induce cell death (Fig. 1C, Fig. 1D).
In an effort to gain insight into the cellular processing of APP in
the presence of lactic acid, we determined the levels of APP in cell
lysates and medium by immunoblot analysis using a monoclonal
antibody, 6E10, which recognizes amino acids 3–8 of b amyloid
(EFRHDS) and binds to full-length APP, the large extracellular
domain of APP secreted upon APP cleavage by a-secretase
(sAPPa?, and Ab peptides [9]. SH-SY5Y cells cultured in 12 mM
lactic acid for 6 h revealed a modest but consistent increase in the
immunoreactivity of both, immature and mature forms of APP in
cell lysates (Fig. 2A, left 2 lanes), and a decrease in the levels of
secreted sAPPa(Fig. 2A, right 2 lanes). Immunoprecipitation
confirmed an increase in APP upon treatment with lactic acid,
but did not reveal association with the heat shock protein 90
(HSP90) (Fig. 2B), which had been implied in early amyloid b
aggregation [14]. Small bands corresponding to Ab peptides,
however, were not detected in repeated western blot analyses and
we therefore used ELISA assays as a more sensitive method for the
detection of Ab peptides. Indeed, 12 mM lactic acid increased the
presence of Ab4? peptides in cultured SH-SY5Y cells (Fig. 3A). A
small but detectable increase in the secretion of Ab42 was also
noted (Fig. 3B). Upon lowering the extracellular pH to 5.5 by
exposure to 12 mM HCl (data not shown), enhanced Ab4?
secretion was also observed (Fig. 3C). These results suggested that
lactic acid affects Ab peptide secretion. One possible mechanism
could be the induction of BACE1 enzyme at lower intracellular
pH levels, since HCl had a similar effect. Using commercially
available kits to assay BACE1 activity (SensiZyme BACE1 Activity
Assay Kit, Sigma, St. Louis, MO), we detected levels of BACE1 in
SH-SY5Y cells that were just at the lower limit of detection and we
did not observe that cells exposed to lactic acid possess levels of
BACE1 activity that were elevated (data not shown). Notably, the
assay system does not permit real-time measurements of BACE1
activity in situ and we are unaware of any assay that could. Thus, at
the present time it is very difficult to know whether the lower
intracellular pH in cells exposed to lactic acid is sufficient to
Figure 1. Lactic acid decreases extra- and intracellular pH. (A) Intracellular pH was measured using the pH-sensitive dye BCECF-AM.
Fluorescence of SH-Y5Y cells exposed to 6 mM and 12 mM LA for 6 h and untreated control cells were scanned using a Leica TCS SP5 Laser Scanning
Confocal Microscope. (B) The pH of culture media was measured with an UltraBasic UB-10 pH/mV meter (A. Daigger & Company, Chicago, IL, USA).
Mean pH levels are noted by horizontal lines. (C) Viability of cells exposed to different concentrations of lactic acid was determined using an MTT Cell
Viability Assay. (D) The percentage of dead (necrotic) cells at different concentrations of lactic acid was determined using Annexin V-FITC and
Propidium iodide fluorescence.
doi:10.1371/journal.pone.0013820.g001
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PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e13820Figure 2. Lactic acid alters APP processing – lowering alpha secretase cleavage in SH-SY5Y cells. (A) APP processing was examined by
immunoblot analysis of cell lysates and culture medium using the monoclonal antibody 6E10, which binds to amino acids 3-8 of APP (EFRHDS) and
therefore detects full-length APP, sAPPa, and Ab. Human SH-SY5Y neuroblastoma cells were cultured in the absence and presence of 12 mM lactic
acid (LA) for 6 h. Accumulation of APP immunoreactivity in cells exposed to lactic acid and decreased levels of sAPPa in medium were detected. (B)
Immunoprecipitation using 6E10 antibody followed by immunoblot confirmed the increased presence of APP in SH-Y5Y cells following exposure to
12 mM lactic acid (upper panel). An abundantly expressed control protein, heat shock protein 90 (HSP90), could not be detected in the immuno-
precipitate (middle and lower panels).
doi:10.1371/journal.pone.0013820.g002
Figure 3. Lactic acid and HCl stimulate the secretion of Ab40 and 42. The levels of Ab40 (A) and 42 (B) were measured by ELISA in culture
medium of SH-SY5Y cells exposed to 12 mM lactic acid for 6 h. (C) Ab40 levels were measured in culture medium of SH-SY5Y cells exposed to 12 mM
HCl for 6 h. The intracellular pH of cells exposed to 12 mM HCl dropped to approximately pH 5.5 (not shown). Mean levels of Ab40 and 42 are noted
by horizontal lines.
doi:10.1371/journal.pone.0013820.g003
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BACE1 activity indicate that the greatest stimulation in activity
occurs at pH 4 [6].
Since the increase in intracellular APP was combined with a
decrease of sAPPa in the culture medium, we hypothesized that
lactic acid has an effect on APP processing through affecting its
intracellular trafficking. Fluorescence microscopy studies were
performed to determine the intracellular localization of APP in
control and lactic acid-treated cells. Diffuse APP staining was
observed in untreated SH-SY5Y (Fig. 4A, upper panels). In
contrast, exposure of cells to 12 mM lactic acid for 24 h resulted in
the perinuclear accumulation of APP immunoreactivity in a subset
of cells (Fig. 4A, lower panels). Interestingly, perinuclear
accumulation of APP was also observed in a subset of cells treated
with 12 mM HCl, although this phenomenon was less consistent
(Fig. 4B). The location of the APP containing structures was
reminiscent of structures previously termed aggresomes [15]. A
hallmark feature of aggresomes is the formation of an intermediate
filament cage, primarily formed by vimentin, around the
aggregated proteinaceous material. Indeed, co-immunostaining
for vimentin and APP demonstrated the occurrence of vimentin
filaments surrounding the inclusion-like structures (Fig. 4C, lower
2 rows and inset). Thus, a small percentage of SH-SY5Y cells
accumulate APP in inclusion bodies with resemblance to
aggresomes upon exposure to lactic acid. Although aggregates
were also present in HCl-treated cells, we were unable to detect
cage-like arrangement of vimentin in these cells.
Transient exposure to acidosis in the range of pH 6.4 to 6.0 has
been shown to induce an ER stress response and increased
expression of glucose-regulated protein 78, Grp78, one of the
major ER-resident chaperone proteins [16,17]. Grp78 was found
to bind to APP both in vitro and in vivo [8,9,10]. To determine
whether altered APP trafficking in lactic acid-treated cells could be
related to the induction of an ER response, levels of Grp78 and
Grp94 were determined. A substantial increase in the expression
of Grp94, and to a lesser extent Grp78, was observed in lactic
acid-treated compared to control SH-SY5Y cells (Fig. 5A).
Furthermore, co-immunoprecipitation studies using an antibody
to the KDEL epitope present in both, Grp78 and Grp94, revealed
increased binding of KDEL proteins to APP of a single molecular
weight corresponding to the immature form in lactic acid-treated
cells (Fig. 5B, upper panel), but no binding to an abundantly
expressed control protein, HSP90 (Fig. 5B, lower panel).
Immunofluorescence microscopy documented a co-localization
of APP and KDEL proteins in cells exposed to lactic acid (Fig. 5C).
In HCl-treated cells, in contrast, APP-KDEL interactions were not
observed.
Taken together these results suggest that lactic acid affects APP
processing by the induction of an ER-stress response with
increased expression of ER chaperone proteins Grp78 and
Grp94 and that increased binding of Grp proteins to APP upon
lactic acid exposure inhibits APP translocation from the ER to the
Golgi compartment and alters APP processing by preventing
exposure to a-secretase (on the cell surface and in the endocytic
compartment), increasing exposure to BACE1 (in the ER/ER-
Golgi intermediate compartment) and inducing APP aggregate
formation by a mechanism not know at this point. It will be the
subject of our further studies to determine, whether Grp protein
interaction with APP is part of a cellular mechanism to prevent
excessive APP aggregate formation in lactic acid-exposed cells or
whether Grp protein binding to APP is part of a general unfolded
protein response aimed at targeting improperly folded and/
or aggregated proteins towards an ER-related degradation
pathway.
Discussion
In the present study, we demonstrate that human neuroblasto-
ma cells, when exposed to physiologically relevant levels of lactic
acid [12], which are within the range of lactic acid levels measured
in the CSF of AD patients [5], secrete higher levels of Ab40 and
42. Lactic acid lowered both the extra- and intracellular pH of
these cultures, however, the overall pH remained well above the
optimum for BACE1, which is reported to be at pH of 4 [6], and
an effect on BACE1 activity could not be detected, suggesting
alternative mechanism(s) underlying the altered APP processing in
lactic acid-treated cells.
As lactate can be taken up by neurons as an energy source (for
review see [18]), one hypothesis would be that the increased
secretion of Ab was due to a metabolic stimulation of neuronal
activity, leading to increased protein synthesis and secretion [19].
Vantelon et al. reported that exposure of astrocytes to 16 mM
lactate did not alter protein synthesis and at pH values below 6,
protein synthesis was decreased [20]. In addition, in the presence
of lactic acid a strong and sustained phosphorylation of the
eukaryotic initiation factor 2a (eIF2a), the central regulator of the
ER stress response, was reported [20]. We observed an increase in
the expression of ER chaperone proteins Grp78 and Grp94 in SH-
SY5Y neuroblastoma cells upon exposure to 12 mM lactic acid
indicating the induction of an ER stress response; a hallmark of
which is a reduction in general protein synthesis. Grp78 has
previously been reported to interact with APP under pharmaco-
logically induced ER stress conditions [9]. We now demonstrate
that physiological lactic acid levels can elicit an ER stress response
and the interaction of APP with Grp78/94 proteins and that this
interaction leads to an alteration in APP processing documented
by increased Ab production, reduced sAPPa secretion, and
retention and aggregation of APP.
Exercise is a very well characterized mechanism to increase
blood lactate levels [12], and exercise has been demonstrated to
play a protective role in AD [21]. Interestingly, studies in
exercising healthy young subjects indicated that lactate taken up
by the brain is metabolized since no increases of lactate in CSF or
within the brain were detected [22]. In contrast, a significant
release of lactate from the brain occurs under hypoxic conditions
[23,24,25] and with extremely low blood pressure [26]; and lactic
acid has clearly been shown to be elevated in the CSF of AD
patients [5]. It is therefore conceivable, that during exercise,
increased lactic acid in AD patients is metabolized and, based on
our data, this would have a beneficial effect on disease progression.
A previous study by Brewer [27] also examined the effect of
lactic acid on the processing of APP and reported increased
accumulation of APP epitopes in primary rat hippocampal
neurons treated with similar concentrations of lactic acid, but
did not observe changes in secreted levels of Ab. However, Brewer
only examined cells that had been exposed to lactic acid for 4 days
and we also observed that long-term incubations of cells with lactic
acid (.48 h) did not produce statistically significant differences in
secreted Ab levels, but we also noted that this observation could be
due to the cellular respiration in both control and lactic acid-
treated cells which raised the levels of lactic acid in medium
significantly over a 4 day period (data not shown).
It was reported previously that Grp78-APP interaction leads to
a decrease in Ab peptide secretion [8,9,28], whereas our data
document increased Ab generation concomitant with increased
Grp-APP interaction in lactic acid-treated cells. It is important to
point out that these studies used cells transfected with the Swedish
mutation of APP (APPswe; K670N/M671L) together with either
wild-type Grp78 or ATPase-mutant Grp78 (T37G), which
Lactate Alters APP Processing
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interaction of polypeptides with Grp78; or used pharmacological
induction of Grp78 overexpression. It is well established that
APPswe distinguishes itself form wild-type APP by its altered
subcellular localization of b-cleavage in the medial Golgi
compartment compared to processing of wild-type APP in the
Figure 4. Lactic acid induces APP aggregation. (A) Fluorescence microscopy studies of SH-SY5Y cells were performed using the 6E10 antibody,
which detects full-length APP, sAPPa, and Ab peptides, respectively. Cells were untreated (Control) or exposed to 12 mM lactic acid (LA) for 24 h,
fixed and stained with 6E10 and DAPI and examined by fluorescence microscopy. Perinuclear APP-positive material was detected in a subset of cells
exposed to lactic acid. (B) Blinded evaluation of cells for the presence of APP-positive inclusions by two independent investigators revealed their
presence in ,2.5% of control cells, 6% of lactic-acid-treated and ,8% of HCl-treated cells. (C) Fluorescence microscopy study of control and lactic
acid-treated SH-SY5Y cells for APP (red) and intermediate filaments (green) using 6E10 and anti-vimentin antibodies, respectively. DNA was visualized
with DAPI stain (blue). Following lactic acid treatment, the occurrence of vimentin filaments surrounding the inclusion-like structures reminiscent of
aggresomes (inset) is observed.
doi:10.1371/journal.pone.0013820.g004
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APPswe could have masked potential effects of Grp chaperone
protein binding on the subcellular processing of APP in these
studies. In contrast, our study used a physiologically relevant
concentration of lactic acid to stimulate neuroblastoma cells that
endogenously express wild-type APP, small amounts of Grp94 and
moderate amounts of Grp78 under unstimulated conditions.
Taken together our results suggest that rather than affecting
BACE1 activity through altering cellular pH, lactic acid modulates
APP processing via induction of an ER stress response and an
increased interaction of APP with ER chaperone proteins and that
this interaction contributes to the retention of APP in an ER/ER-
Golgi-intermediate compartment, which leads to (i) reduced
exposure to a-secretase and reduced sAPPa, and (ii) exposure to
BACE1 leading to elevated Ab levels. We can not rule out at this
point that the differences in Ab secretion upon APP interaction
with KDEL proteins in our study and the studies previously
reported is not based on the different nature of the interacting
KDEL protein. Interaction of Grp78 with APP has been
extensively reported [8,9], but it is possible that APP binding to
Grp94, which is readily induced by lactic acid treatment in our
study, is involved in the observed increase in Ab secretion.
Our results might have relevance for the use of therapeutics to
reduce Ab production, since aberrant subcellular APP processing
in an early secretory compartment has recently been demonstrated
to affect the efficacy of b-secretase inhibitors [30], and it needs to
Figure 5. Lactic acid increases the expression of ER stress–dependent chaperone proteins Grp78 and Grp94 and enhances their
interaction with APP. (A) Immunoblot analysis of SH-SY5Y cell lysates in the absence and presence of 12 mM lactic acid was performed using an
antibody to the ER retrieval sequence KDEL, which is present in both, Grp78 and Grp94 proteins. Increased expression of Grp94 and to a lesser extent
Grp78, was detected upon lactic acid treatment. (B) Immunoprecipitation using the anti-KDEL antibody revealed the increased presence of APP in
complex with KDEL proteins following exposure of cells to lactic acid. An abundantly expressed control protein, heat shock protein 90 (HSP90, lower
right panel), could not be detected in the immunoprecipitate (lower left panel). (C) Fluorescence microscopy study of APP using 6E10 (green) and
KDEL proteins (red) documented co-localization (yellow) of APP and KDEL proteins in SH-SY5Y cells exposed to lactic acid.
doi:10.1371/journal.pone.0013820.g005
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inhibitors is reduced in patients that are at risk for increased
lactic acid levels in the brain.
Materials and Methods
Cell culture and measurements of Ab, lactate, and
cytotoxicity
Human neuroblastoma cells (SH-SY5Y) were cultured at
steady-state of semi-confluency in 6-well plates in DMEM
(Invitrogen, Carlsbad, CA), supplemented with 10% fetal bovine
serum, 1 mM L-glutamine, and 100 U/ml penicillin and 100 mg/
ml streptomycin at 37uC with 5% CO2. Media were harvested
from cells that were placed in OPTI-MEM serum-free medium
(Invitrogen, Carlsbad, CA) supplemented with lactic acid at 6 mM
or 12 mM and incubated at 37uC for 6 or 24 h. Lactate
concentrations in medium were detected using the Lactate Assay
Kit from Biomedical Research Service Center (University at
Buffalo, Buffalo, NY).
Ab40 and Ab42 ELISA assay kits were purchased from
Invitrogen BioSource (Carlsbad, CA), protein assay kits from
ThermoScientific-Pierce (Waltham, MA), and 6E10 monoclonal
antibodies to APP and Abfrom Covance (Princeton, NJ).
Cytotoxicity assays were performed using a MTT Cell
Proliferation Assay Kit from Biotium, Inc. (Hayward, CA) and
standard microplate absorbance readers, and an Annexin V-FITC
Apoptosis Detection Kit from Abcam (Cambridge, MA).
Measurement of extra- and intracellular pH
The pH of culture media was measured under incubator
conditions (CO2 5%, 37uC) with an UltraBasic UB-10 pH/mV
meter (A. Daigger & Company, Chicago, IL, USA). Intracellular
pH measurements were performed by incubating cells with pH-
sensitive dye (BCECF, AM) following protocols provided by the
manufacturer (Invitrogen, Carlsbad,CA). BCECF, AM was added
to the culture medium to a final concentration of 5 mM. Cells were
incubated for 15 min and then washed. Fluorescence was
observed with a Leica TCS SP5 Laser Scanning Confocal
Microscope running Leica LAS-AF software. Detection of BCECF
fluorescence used a dual-excitation ratio with l1=488 nm and
l2=465 nm and fixed emission at 558 nm.
Immunoprecipitation
Immunoprecipitations (IPs) were performed using the Protein-G
Immunoprecipitation Kit from Sigma (St. Louis, MO). Protein-G
agarose beads were washed three times with IP buffer, incubated
with 6E10 antibodies (Covance, Princeton, NJ) or KDEL
antibodies (MBL Inc., Woburn, MA) for 1 h at room temperature.
Two hundred micrograms of protein were added to 400 mlo fI P
buffer and 20 ml of protein-G agarose beads/primary antibody
mixture. This mixture was gently mixed overnight at 4uCo na
rocker. The agarose beads were collected by pulse centrifugation
(5 seconds in the microcentrifuge at 13,000 rpm), the supernatant
was discarded and beads were washed 5 times with 800 mlI P
buffer. Finally, immunoprecipitated proteins were subjected to
SDS-PAGE protein separation followed by western blot with APP
and KDEL antibodies.
Immunoblot
Immunoblotting was performed on cell lysates and medium
proteins (20 mg protein per lane) separated by SDS-PAGE before
transfer to nitrocellulose membrane (Amersham Bioscience,
Uppsala, Sweden). After blocking in PBS with 5% milk,
membranes were incubated overnight at 4uC with the primary
antibodies; then washed and incubated with secondary antibodies
conjugated to horseradish peroxidase (HRP), followed by
incubation with Immobilon Western Chemiluminescent HRP
Substrate (Millipore, Billerica, MA). The HSP90 antibody was
purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA).
Immunocytochemistry
SH-SY5Y cells were grown in 4-well chamber slides. Cells were
treated with 12 mM lactic acid for 6 h and subsequently fixed with
4% paraformaldehyde in PBS, washed and incubated for 72 h at
4uC with 6E10 primary antibodies at a dilution of 1:100 in PBS
containing 5% normal goat serum and 0.1% Triton X-100. After
washing 5 times with PBS, slides were incubated with KDEL
primary antibodies at a dilution of 1:100 in PBS containing 5%
normal goat serum and 0.1% Triton X-100 for 24 h at 4uC. Slides
were washed 5 times in PBS and incubated consecutively with
secondary anti-mouse IgG1-FITC antibodies and secondary anti-
IgG2a-PE antibodies for 1 h at room temperature. The cover slips
were washed 5 times with PBS, dried and mounted on slides. The
slides were analyzed using a Zeiss Axioskop 2 fluorescence
microscope (Carl Zeiss Microimaging Inc. Thornwood, NY) using
the appropriate filters.
Statistical Analysis
All experiments were performed at least 3 times. Data for
measurements of pH levels and Ab levels are presented as scatter
plots and mean values. Statistical analyses used standard Student’s
t-test and differences between untreated and treated groups were
deemed significant at p,0.05.
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